BHVN

BHVN · Biohaven Ltd. Common Shares

View on chart

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 13, 2026

Biohaven signs $100M deal with Ono for IgG degraders. Biohaven has entered a strategic licensing agreement with Ono Pharma for its IgG degrader technology in Japan and select Asian regions. The deal includes up to $100 million in near-term payments, with $80 million paid upfront. This move expands the company's presence in Asia and supports its lead candidate, BHV-1300, which is currently in Phase 3 trials for Graves' disease.

this person other insiders at BHVN

Insiders & Stakes

John W. Childs
Director
5,653,904
Shares held
Gregory Bailey
Director
2,020,071
Shares held
Vlad Coric
Director
1,803,968
Shares held
Buten Matthew
Chief Financial Officer
195,652
Shares held
Gentile Kimberly
SVP, Clinical Operations
99,557
Shares held
Clark George C.
VP, Chief Accounting Officer
66,978
Shares held
GREGORY JULIA P
Director
25,665
Shares held
HUGIN ROBERT J
Director
19,486
Shares held
Heffernan Michael Thomas
Director
19,370
Shares held
Mehta Kishan17,342
Shares held
Car Bruce
Chief Scientific Officer
7,715
Shares held
Antonijevic Irina2,535
Shares held
Biohaven Pharmaceutical Holding Co Ltd.0
Shares held

Transaction History

Mehta Kishan▼ Sell$0
Mehta Kishan▼ Sell$0
Buten Matthew▲ Buy$0
Buten Matthew▼ Sell$26K
Vlad Coric▲ Buy$0
Vlad Coric▼ Sell$74K
Car Bruce▼ Sell$24K
Clark George C.▲ Buy$0
Clark George C.▼ Sell$11K
Gentile Kimberly▲ Buy$0
Gentile Kimberly▼ Sell$19K
Car Bruce▲ Buy$0
Clark George C.▲ Buy$145K
John W. Childs▲ Buy$25.0M
Vlad Coric▲ Buy$2.5M
Vlad Coric▲ Buy$2.5M
Gregory Bailey▲ Buy$3.0M
John W. Childs▲ Buy$760K
John W. Childs▲ Buy$104K
John W. Childs▲ Buy$104K
John W. Childs▲ Buy$28K
Car Bruce▲ Buy$0
Car Bruce▼ Sell$90K
Gentile Kimberly▲ Buy$0
Gentile Kimberly▼ Sell$76K
Clark George C.▲ Buy$0
Clark George C.▼ Sell$43K
Buten Matthew▲ Buy$0
Buten Matthew▼ Sell$99K
Vlad Coric▲ Buy$0
Vlad Coric▼ Sell$263K
John W. Childs▲ Buy$1.0M
John W. Childs▲ Buy$1000K
Vlad Coric▲ Buy$1000K
Gregory Bailey▲ Buy$221K
John W. Childs▲ Buy$1.0M
Car Bruce▲ Buy$1.0M
John W. Childs▲ Buy$996K
John W. Childs▲ Buy$1.0M
Gregory Bailey▲ Buy$513K
Gregory Bailey▲ Buy$999K
Gregory Bailey▲ Buy$2.0M
John W. Childs▲ Buy$1.0M
John W. Childs▲ Buy$4.0M
John W. Childs▲ Buy$3.0M
Vlad Coric▲ Buy$5.0M
Vlad Coric▲ Buy—
Vlad Coric▲ Buy—
John W. Childs▲ Buy—
Vlad Coric▲ Buy—
Vlad Coric▲ Buy—
Vlad Coric▲ Buy—
Vlad Coric▲ Buy—
John W. Childs▲ Buy—
Vlad Coric▲ Buy—
Vlad Coric▲ Buy—
John W. Childs▼ Sell—
Vlad Coric▲ Buy—
Antonijevic Irina▲ Buy$0
Antonijevic Irina▼ Sell$460K
John W. Childs▲ Buy$3.0M
Vlad Coric▲ Buy$2.5M
John W. Childs▲ Buy$7.0M
Buten Matthew▲ Buy$500K
Vlad Coric▲ Buy$7.5M
Gregory Bailey▲ Buy$402K
John W. Childs▲ Buy$922K
John W. Childs▲ Buy$2.0M
Vlad Coric▲ Buy$412K
Vlad Coric▲ Buy$623K
Vlad Coric▲ Buy$1.5M
Gregory Bailey▲ Buy$2.1M
Vlad Coric▲ Buy$9.0M
John W. Childs▲ Buy$41.0M
Buten Matthew▲ Buy$1.5M
GREGORY JULIA P▲ Buy$100K
Vlad Coric▲ Buy$26K
John W. Childs▲ Buy$2.1M
John W. Childs▲ Buy$318K
Vlad Coric▲ Buy$647K
Vlad Coric▲ Buy$342K
Vlad Coric▲ Buy$876K
Vlad Coric▲ Buy$643K
Vlad Coric▲ Buy$644K
Vlad Coric▲ Buy$341K
Vlad Coric▲ Buy$872K
Vlad Coric▲ Buy$619K
Heffernan Michael Thomas▲ Buy$20K
Heffernan Michael Thomas▲ Buy$21K
Heffernan Michael Thomas▼ Sell$41K
Gentile Kimberly▲ Buy$2K
Gentile Kimberly▲ Buy$57K
Gentile Kimberly▲ Buy$40K
Gentile Kimberly▲ Buy$50K
Gentile Kimberly▲ Buy$2K
Gentile Kimberly▲ Buy$304
Gentile Kimberly▲ Buy$21K
GREGORY JULIA P▲ Buy$20K
GREGORY JULIA P▲ Buy$21K
GREGORY JULIA P▲ Buy$28K
GREGORY JULIA P▼ Sell$90K
John W. Childs▲ Buy$20K
John W. Childs▲ Buy$21K
John W. Childs▼ Sell$41K
HUGIN ROBERT J▲ Buy$20K
HUGIN ROBERT J▼ Sell$24K
Buten Matthew▲ Buy$10K
Buten Matthew▲ Buy$73K
Gregory Bailey▲ Buy$20K
Gregory Bailey▲ Buy$21K
Gregory Bailey▲ Buy$28K
Vlad Coric▲ Buy$10K
Vlad Coric▲ Buy$93K
Vlad Coric▲ Buy$11K
Vlad Coric▲ Buy$12K
Vlad Coric▲ Buy$14K
Vlad Coric▲ Buy$5K
Vlad Coric▼ Sell$870K
GREGORY JULIA P▲ Buy$21K
Gentile Kimberly▲ Buy$8K
Gentile Kimberly▲ Buy$80K
Gregory Bailey▲ Buy$21K
Mehta Kishan▼ Sell$82K
Buten Matthew▼ Sell$83K
HUGIN ROBERT J▲ Buy$21K
Vlad Coric▲ Buy$11K
Mehta Kishan▲ Buy$19K
Mehta Kishan▲ Buy$19K
Gregory Bailey▼ Sell$90K
Gentile Kimberly▼ Sell$0
HUGIN ROBERT J▼ Sell$0
HUGIN ROBERT J▲ Buy$32K
Heffernan Michael Thomas▲ Buy$31K
John W. Childs▼ Sell$0
Gentile Kimberly▼ Sell$0
Gentile Kimberly▼ Sell$0
Heffernan Michael Thomas▼ Sell$0
Gregory Bailey▼ Sell$0
Gentile Kimberly▲ Buy$5K
HUGIN ROBERT J▼ Sell$0
Buten Matthew▼ Sell$0
Gentile Kimberly▼ Sell$0
Vlad Coric▼ Sell$0
Buten Matthew▼ Sell$0
Gentile Kimberly▲ Buy$8K
Gentile Kimberly▲ Buy$7K
Gentile Kimberly▼ Sell$262K
Antonijevic Irina▼ Sell$0
Biohaven Pharmaceutical Holding Co Ltd.▼ Sell$0
Biohaven Pharmaceutical Holding Co Ltd.▼ Sell$0
Mehta Kishan▼ Sell$0
Mehta Kishan▼ Sell$0
Mehta Kishan▲ Buy$20K
Mehta Kishan▲ Buy$30K
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▼ Sell$0
Vlad Coric▲ Buy$2K
Vlad Coric▲ Buy$220K
Vlad Coric▲ Buy$5K
Vlad Coric▲ Buy$202K
Vlad Coric▲ Buy$124K
Vlad Coric▲ Buy$159K
Vlad Coric▲ Buy$2K

We use analytics to understand how market-wall is used. No personal data is sold.